Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)

Megan Crumbaker, Sarennya Pathmanandavel, Andrew O. Yam, Andrew Nguyen, Bao Ho, Lyn Chan, Jesse A. Ende, Christopher Rofe, Kamonwan Kongrak, Edmond M. Kwan, Arun Azad, Shikha Sharma, Trevor J. Pugh, Arnavaz Danesh, Joanne Keane, Peter Eu, Anthony M. Joshua, Louise Emmett